Natilus Partners with Janicki on Air Freight Transport Prototype  

CA – Natilus, a U.S. corporation, is producing the world’s first purposefully designed and manufactured autonomous aircraft for air freight transport. As a big step forward, the company has partnered with Janicki for composite part design and fabrication due to its renowned reputation for innovation and quality workmanship as a tier 1 supplier. Through Natilus’ design and development of a primarily composite, blended-wing body, autonomous aircraft, the company will provide customers with double the cargo volume for each trip while simultaneously reducing up to 60% of today’s cargo transport cost. On top of the customer benefits, the technology and unique shape of the blended wing body also thrust aerospace toward a greener future with a 50% reduced carbon footprint per vehicle and a clear path to zero emissions with hydrogen. Natilus’ N3.8T is scheduled to fly in 2024. 

“We selected Janicki because they are a family-owned and operated company, founded and run by engineers with the highest qualifications and experience in designing large-scale, high-precision prototypes, tools, and production parts,” said Natilus CEO Aleksey Matyushev. 

“Janicki is pleased to partner with Natilus on the 3.8T prototype. Autonomous aircraft are the future of the air freight industry, and we are extremely excited to be working on this leading-edge project,” said John Janicki, president of Janicki. 

Environmental Stewards 

Janicki also shares the Natilus commitment to producing the most advanced and sustainable products while being responsible stewards of our environment, instituting practices that protect the environment through continual improvements to save fuel and water and reduce waste, air emissions, noise, and material consumption. In 2011, Janicki worked with the Bill and Melinda Gates Foundation to create a low-cost waste treatment plant, later establishing their sister company, Sedron Technologies. Sedron continues to develop cost-effective waste and water treatment solutions globally.